Literature DB >> 322920

Free-living volunteer's motivations and attitudes toward pharmacologic studies in man.

M Hassar, R Pocelinko, M Weintraub, D Nelson, G Thomas, L Lasagna.   

Abstract

Two groups of volunteers who had participated in pharmacologic studies were interviewed about their impressions of such studies. One group was from a university community, the other from the pharmaceutical industry. The differences between the two groups were correlated with their respective backgrounds. Both groups had favorable impressions about drug studies and investigators. Most were satisfied with the information given them about the nature and risks of the studies, but some believed that a written description of the study that they could consult at home would improve their understanding of the information. Financial reward was the primary reason given by both groups for volunteering, but the perceived risk of the study was the ultimate deciding factor. The volunteers disliked having their mobility restricted and for this reason might not be willing to participate in long-term studies, such as those formerly carried out in prisons. Alternative sources of volunteers for long-term studies will have to be found.

Entities:  

Mesh:

Year:  1977        PMID: 322920     DOI: 10.1002/cpt1977215515

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

1.  Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials.

Authors:  J Bigorra; J E Baños
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Sensation seeking amongst healthy volunteers participating in phase I clinical trials.

Authors:  M Farré; X Lamas; J Camí
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

3.  Payment of clinical research subjects.

Authors:  Christine Grady
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

4.  Motives and perception of healthy volunteers who participate in experiments.

Authors:  C E van Gelderen; T J Savelkoul; W van Dokkum; J Meulenbelt
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Who's doing the math? Are we really compensating research participants?

Authors:  Elizabeth Ripley; Francis Macrina; Monika Markowitz; Chris Gennings
Journal:  J Empir Res Hum Res Ethics       Date:  2010-09       Impact factor: 1.742

6.  Paying research subjects: participants' perspectives.

Authors:  M L Russell; D G Moralejo; E D Burgess
Journal:  J Med Ethics       Date:  2000-04       Impact factor: 2.903

Review 7.  More than the money: a review of the literature examining healthy volunteer motivations.

Authors:  Leanne Stunkel; Christine Grady
Journal:  Contemp Clin Trials       Date:  2010-12-10       Impact factor: 2.226

8.  Why healthy subjects volunteer for phase I studies and how they perceive their participation?

Authors:  Luis Almeida; Benedita Azevedo; Teresa Nunes; Manuel Vaz-da-Silva; Patrício Soares-da-Silva
Journal:  Eur J Clin Pharmacol       Date:  2007-09-20       Impact factor: 2.953

9.  Patients' attitudes to participation in clinical trials.

Authors:  E G Bevan; L C Chee; S M McGhee; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

10.  Phase 1 healthy volunteer willingness to participate and enrollment preferences.

Authors:  Stephanie C Chen; Ninet Sinaii; Gabriella Bedarida; Mark A Gregorio; Ezekiel Emanuel; Christine Grady
Journal:  Clin Trials       Date:  2017-08-02       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.